Understanding the Empower Hereditary Cancer Screening Test
The Empower hereditary cancer test is a genetic screening tool that analyzes your DNA for mutations associated with an increased risk of developing certain types of cancer. Unlike general cancer screening tests that look for signs of existing cancer, hereditary genetic testing identifies inherited genetic variants that may predispose you to cancer before any disease develops. At TrufaMED in Surfside, FL, we offer the Empower test as part of our commitment to proactive, preventive healthcare for our Miami-area patients.
What Does the Empower Test Screen For?
The Empower hereditary cancer screening test evaluates genes associated with hereditary cancer syndromes, including mutations in BRCA1 and BRCA2 genes linked to breast and ovarian cancer, Lynch syndrome genes associated with colorectal and endometrial cancer, and other high-penetrance cancer predisposition genes. The test uses a simple blood draw or saliva sample collected at our Surfside clinic and sent to a certified genetic laboratory for analysis. Results are typically available within two to three weeks.
How Much Does the Empower Test Cost?
The cost of hereditary cancer genetic testing has decreased significantly in recent years. At TrufaMED, we work with patients to understand the out-of-pocket cost before testing. Many insurance plans cover hereditary cancer genetic testing when clinical criteria are met, such as a family history of cancer at a young age or multiple family members with related cancers. For patients without insurance coverage, self-pay options are available, and the testing company may offer financial assistance programs that reduce the cost for qualifying patients. Our team can help you navigate these options during your consultation.
Who Should Consider the Empower Test?
Hereditary cancer screening is particularly recommended for individuals with a personal or family history of cancer diagnosed before age 50, multiple family members with the same type of cancer, family members with known hereditary cancer gene mutations, ancestry groups with higher prevalence of certain mutations such as Ashkenazi Jewish heritage, and anyone who wants to understand their genetic cancer risk as part of a comprehensive preventive health plan.
Even without a known family history of cancer, some patients choose genetic screening for peace of mind or to inform lifestyle and screening decisions. A negative result does not eliminate cancer risk but can provide reassurance that you do not carry the specific high-risk mutations tested.
What Happens After You Get Your Results
If your Empower test identifies a hereditary cancer gene mutation, it does not mean you have cancer or will definitely develop cancer. It means your risk is elevated compared to the general population, and your physician can develop a personalized surveillance and prevention plan. This may include more frequent cancer screenings starting at an earlier age, consultations with genetic counselors and oncology specialists, lifestyle modifications that may reduce risk, and discussions about preventive medical interventions for very high-risk mutations.
At TrufaMED, our physician reviews your results with you in a dedicated appointment, explains what the findings mean for your health, and helps you develop a next-steps plan. We coordinate with genetic counselors and specialists as needed to ensure you receive comprehensive support.
Knowledge is power in cancer prevention. Learn more about Empower testing at TrufaMED or call (305) 537-6396 to schedule your screening.
Understanding the Empower Hereditary Cancer Test
The Empower hereditary cancer test is a comprehensive genetic screening panel that analyzes multiple genes associated with increased risk for various hereditary cancers. Unlike single-gene tests that only examine BRCA1 and BRCA2, the Empower panel evaluates a broader set of genes linked to breast, ovarian, colorectal, prostate, pancreatic, uterine, stomach, and other hereditary cancer syndromes. This multi-gene approach provides a more complete picture of your genetic cancer risk profile and can identify predispositions that single-gene testing would miss.
Hereditary cancer syndromes account for approximately 5-10 percent of all cancers. Identifying a genetic predisposition allows for enhanced surveillance protocols, preventive interventions, and risk-reduction strategies that can dramatically improve outcomes. For family members of those with known hereditary cancer mutations, cascade testing identifies who else in the family carries the variant and who does not, enabling personalized screening recommendations for each individual.
How Much Does the Empower Test Cost and Is It Covered by Insurance
The cost of the Empower hereditary cancer test varies based on insurance coverage and specific panel selection. Many health insurance plans cover genetic cancer testing when clinical criteria are met, such as a strong family history of cancer, a personal cancer diagnosis at a young age, or certain ethnic backgrounds with known elevated genetic cancer risk (for example, Ashkenazi Jewish ancestry carries higher BRCA mutation rates). When insurance covers the test, patient responsibility is typically limited to applicable copays and deductibles.
For patients without insurance coverage or who do not meet clinical criteria for covered testing, self-pay options are available. The cost of multi-gene panels has decreased significantly in recent years as genetic testing technology has advanced, making comprehensive hereditary cancer screening more accessible than ever before.
Getting Tested at TrufaMED in Surfside
TrufaMED offers the Empower hereditary cancer test with a streamlined process. Testing requires only a simple saliva or blood sample collected at our Surfside clinic. Results are typically available within 2-3 weeks and are reviewed with you in a detailed consultation where our physicians explain your results, discuss implications, and outline recommended next steps including enhanced screening schedules or specialist referrals for positive findings. Contact us to schedule your genetic cancer risk assessment.
